Abstract:Calcineurin is a calcium/calmodulin-regulated phosphatase known for its role in activation of T cells following engagement of the T cell receptor. Calcineurin inhibitors (CNIs) are widely used as immunosuppressive agents; common adverse effects of CNIs are hypertension and hyperkalemia. While previous studies have implicated activation of the Na-Cl cotransporter (NCC) in the renal distal convoluted tubule (DCT) in this toxicity, the molecular mechanism of this effect is unknown. The renal effects of CNIs mimic the hypertension and hyperkalemia that result from germ-line mutations in with-no-lysine (WNK) kinases and the Kelch-like 3 (KLHL3)-CUL3 ubiquitin ligase complex. WNK4 is an activator of NCC and is degraded by binding to KLHL3 followed by WNK4's ubiquitylation and proteasomal degradation. This binding is prevented by phosphorylation of KLHL3 at serine 433 (KLHL3S433-P) via protein kinase C, resulting in increased WNK4 levels and increased NCC activity. Mechanisms mediating KLHL3S433-P dephosphorylation have heretofore been unknown. We now demonstrate that calcineurin expressed in DCT is a potent KLHL3S433-P phosphatase. In mammalian cells, the calcium ionophore ionomycin, a calcineurin activator, reduces KLHL3S433-P levels, and this effect is reversed by the calcineurin inhibitor tacrolimus and by siRNA-mediated knockdown of calcineurin. In vivo, tacrolimus increases levels of KLHL3S433-P, resulting in increased levels of WNK4, phosphorylated SPAK, and NCC. Moreover, tacrolimus attenuates KLHL3-mediated WNK4 ubiquitylation and degradation, while this effect is absent in KLHL3 with S433A substitution. Additionally, increased extracellular K+ induced calcineurin-dependent dephosphorylation of KLHL3S433-P These findings demonstrate that KLHL3S433-P is a calcineurin substrate and implicate increased KLHL3 phosphorylation in tacrolimus-induced pathologies.

Activities and Properties of Calcineurin Catalytic Domain

The Secondary Structure of Calcineurin Regulatory Region and Conformational Change Induced by Calcium/Calmodulin Binding*

The role of loop 7 in mediating calcineurin regulation

Cooperative autoinhibition and multi-level activation mechanisms of calcineurin

Cloning and Expression Analysis of a Tomato Full-Length Cdna Encoding a Putative Catalytic Subunit of Calcineurin-Like Phosphatase

Mechanism of activation of<i>Saccharomyces cerevisiae</i>calcineurin by Mn<sup>2+</sup>

Identification of the role of a cysteine-rich region of PC6B by determining the enzymatic characteristics of its mutants

Biochemical analyses reveal new insights into RCAN1/Rcn1 inhibition of calcineurin

Functional Study Of Cbs Domain Interaction During Common Gating Of Clc-0 Chloride Channel

Usp16-Mediated Deubiquitination Of Calcineurin A Controls Peripheral T Cell Maintenance

Structure of Calcineurin bound to PI4KA reveals dual interface in both PI4KA and FAM126A

La 3+ Stimulate the Activity of Calcineurin in Two Different Ways

Calcineurin Dephosphorylates Kelch-like 3, Reversing Phosphorylation by Angiotensin II and Regulating Renal Electrolyte Handling.

Distribution and Activity of Calcineurin in Different Tissues of Rat

CK1δ Kinase Activity is Modulated by Protein Kinase C Α (Pkcα)-Mediated Site-Specific Phosphorylation.

An Approach to Assay Calcineurin Activity and the Inhibitory Effect of Zinc Ion.

FKBP12-BOUND CALCINEURIN CONTROL TMEM16A ACTIVITY

P38α MAP Kinase Phosphorylates RCAN1 and Regulates Its Interaction with Calcineurin

Silencing calcineurin A subunit reduces SERCA2 expression in cardiac myocytes

Calcineurin is an adaptor required for assembly of the TCR signaling complex

Activation of a Ca(2+)-dependent protein kinase involves intramolecular binding of a calmodulin-like regulatory domain